Education
About Us
Working with TipRanks
Follow Us
Relief Therapeutics Holding Ag (CH:RLF)
:RLF
RESEARCH TOOLSreports
See the Price Targets and Ratings of:
RLF Financial Forecast
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TipRanks
CHF2
Hold
-8.26%
Downside
Reiterated
07/09/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TipRanks
CHF2
Hold
-8.26%
Downside
Reiterated
07/09/25
RLF Analyst Recommendation Trends
Rating
May 25
Strong Buy
0
Buy
0
Hold
1
Sell
0
Strong Sell
0
total
1
Each month's total comprises the sum of three months' worth of ratings.
RLF Stock Forecast FAQ
What is CH:RLF’s average 12-month price target, according to analysts?
Based on analyst ratings, Relief Therapeutics Holding Ag’s 12-month average price target is 2.50.
What is CH:RLF’s upside potential, based on the analysts’ average price target?
Relief Therapeutics Holding Ag has 14.69% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Relief Therapeutics Holding Ag a Buy, Sell or Hold?
Relief Therapeutics Holding Ag has a consensus rating of Hold, which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
What is Relief Therapeutics Holding Ag’s share price target?
The average share price target for Relief Therapeutics Holding Ag is 2.50. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is CHF2.50 ,and the lowest forecast is CHF2.50. The average share price target represents 14.69% Increase from the current price of CHF2.18.
The highest analyst share price target is CHF2.50 ,and the lowest forecast is CHF2.50. The average share price target represents 14.69% Increase from the current price of CHF2.18.
What do analysts say about Relief Therapeutics Holding Ag?
Relief Therapeutics Holding Ag’s analyst rating consensus is a Hold. This is based on the ratings of 0 Wall Streets Analysts.
How can I buy shares of Relief Therapeutics Holding Ag?
To buy shares of CH:RLF, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.